Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Comment by Smokey1958on Jan 30, 2021 11:24am
246 Views
Post# 32428204

RE:RE:Therma

RE:RE:Therma

optex, with all due respect but do some of you guys even read the News Releases. It is stated explicitly, the testing will take place in February. Even if it's late February, putting together the application for review by government health agencies will take no time at all. If the tests are as positive as expected the review, certainly for HC, will go to the TOP of the queue as there is NOTHING like it currently under review ....and the demand and need is WORLWIDE.

DON'T guess when the most important fact has already been stated in the NR from 5 days ago. EVERY date implied by Thrm in an NR since the concept of SCV2 was first broached has been spot on. Go back and read them ALL.

Cheers!

GLTA!!!

 

optex1972 wrote: Likley no why would they? Long ways away from anything happening still all in prototype stage. Maybe by April
theyll have some testing done and be able to present to HC and say June to July maybe submit for review. That's guess anyhow 

 

<< Previous
Bullboard Posts
Next >>